AAAAAA

   
Results: 1-9 |
Results: 9
AN EXTENSIVE EWINGS-SARCOMA OF THE LEFT ISCHIUM TREATMENT BY OPTIMAL SYSTEMIC CHEMOTHERAPY, INTRAARTERIAL DACTINOMYCIN, AND DELAYED IRRADIATION
Authors: CANPOLAT C EIFEL PT MOULOPOULOS LA CANGIR A
Citation: C. Canpolat et al., AN EXTENSIVE EWINGS-SARCOMA OF THE LEFT ISCHIUM TREATMENT BY OPTIMAL SYSTEMIC CHEMOTHERAPY, INTRAARTERIAL DACTINOMYCIN, AND DELAYED IRRADIATION, International journal of pediatric hematology/oncology, 4(2), 1997, pp. 137-142
HIGH-DOSE MERCAPTOPURINE AND INTERMEDIATE-DOSE CYTARABINE DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA
Authors: CANPOLAT C JEHA S LOCKHART S RAMIREZ I ZIPF T PINKEL D
Citation: C. Canpolat et al., HIGH-DOSE MERCAPTOPURINE AND INTERMEDIATE-DOSE CYTARABINE DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA, Cancer investigation, 15(2), 1997, pp. 121-126
COMMON VARIABLE IMMUNODEFICIENCY AND HODGKIN LYMPHOMA
Authors: BERRAK SG CANPOLAT C BARLAN I KOTILOGLU E BASARAN M
Citation: Sg. Berrak et al., COMMON VARIABLE IMMUNODEFICIENCY AND HODGKIN LYMPHOMA, Blood, 90(10), 1997, pp. 3872-3872
PRIMARY POLYCYTHEMIA-VERA IN CHILDHOOD
Authors: BERRAK SG CANPOLAT C
Citation: Sg. Berrak et C. Canpolat, PRIMARY POLYCYTHEMIA-VERA IN CHILDHOOD, Blood, 90(10), 1997, pp. 4057-4057
GANCICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS-INFECTION IN PEDIATRIC ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
Authors: CANPOLAT C CULBERT S GARDNER M WHIMBEY E TARRAND J CHAN KW
Citation: C. Canpolat et al., GANCICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS-INFECTION IN PEDIATRIC ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 17(4), 1996, pp. 589-593
FIBROMYXOID SARCOMA IN A 4-YEAR-OLD CHILD - CASE-REPORT AND REVIEW OFTHE LITERATURE
Authors: CANPOLAT C EVANS HL CORPRON C ANDRASSY RJ CHAN KW EIFEL P ELIDEMIR O RANEY B
Citation: C. Canpolat et al., FIBROMYXOID SARCOMA IN A 4-YEAR-OLD CHILD - CASE-REPORT AND REVIEW OFTHE LITERATURE, Medical and pediatric oncology, 27(6), 1996, pp. 561-564
IFOSFAMIDE TOLERANCE IN OSTEOSARCOMA PATIENTS PREVIOUSLY TREATED WITHCIS-DIAMMINEDICHLOROPLATINUM-II - RENAL, HEMATOLOGIC, AND NEUROLOGIC OBSERVATIONS
Authors: CANPOLAT C PEARSON P ROBERTSON R JAFFE N
Citation: C. Canpolat et al., IFOSFAMIDE TOLERANCE IN OSTEOSARCOMA PATIENTS PREVIOUSLY TREATED WITHCIS-DIAMMINEDICHLOROPLATINUM-II - RENAL, HEMATOLOGIC, AND NEUROLOGIC OBSERVATIONS, Medical and pediatric oncology, 26(1), 1996, pp. 36-47
WILMS-TUMOR - CURE OF MALIGNANT PLEURAL EFFUSION EXCLUSIVELY WITH CHEMOTHERAPY
Authors: CANPOLAT C JAFFE N
Citation: C. Canpolat et N. Jaffe, WILMS-TUMOR - CURE OF MALIGNANT PLEURAL EFFUSION EXCLUSIVELY WITH CHEMOTHERAPY, Medical and pediatric oncology, 24(4), 1995, pp. 274-277
CISPLATIN-ASSOCIATED HEMOLYTIC-UREMIC SYNDROME
Authors: CANPOLAT C PEARSON P JAFFE N
Citation: C. Canpolat et al., CISPLATIN-ASSOCIATED HEMOLYTIC-UREMIC SYNDROME, Cancer, 74(11), 1994, pp. 3059-3062
Risultati: 1-9 |